LOCALLY ADVANCED SOLID TUMOR
Clinical trials for LOCALLY ADVANCED SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED SOLID TUMOR trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for cancer patients when immunotherapy fails?
Disease control CompletedThis early-stage study tested a new drug called CTX-471, given alone or with another immunotherapy (pembrolizumab), in 100 adults with advanced cancers like lung cancer, melanoma, or head and neck cancer that had stopped responding to standard PD-1/PD-L1 inhibitors. The main goal…
Matched conditions: LOCALLY ADVANCED SOLID TUMOR
Phase: PHASE1 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated May 26, 2026 04:53 UTC
-
Immune cell therapy shows promise in early cancer trial
Disease control CompletedThis early-phase study tested a new immune cell treatment called PD-L1 t-haNK in 16 adults with advanced solid cancers that had spread or could not be removed. The main goals were to check safety, find the best dose, and see if the treatment could shrink tumors. The approach uses…
Matched conditions: LOCALLY ADVANCED SOLID TUMOR
Phase: PHASE1 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated May 26, 2026 04:36 UTC